The Lymphoma Program is part of the Hematologic Oncology Treatment Center. Our specialists are experienced in providing treatment and care for the many varieties of lymphoid malignancies, including non-Hodgkin lymphoma, Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), B-cell neoplasms, and T-cell neoplasms. Your care will involve the best and most advanced treatments currently available, combined with new therapies based on research in our laboratories and elsewhere in the field of lymphoma treatment.
Our Treatment Approach
Our program offers patients access to a multidisciplinary team of lymphoma experts with extensive experience caring for patients with lymphoid malignancies. This experience is particularly important because of the complexity of this type of cancer: There are more than 70 tumor types, each with a unique natural history and each requiring a different approach to treatment.
We provide comprehensive services to patients with lymphoma, including:
- evaluation
- second opinions
- diagnosis (pathologic)
- a personalized treatment plan offering the latest therapies
- immunotherapy approaches including checkpoint inhibitors and CAR T-cell therapy
- access to clinical trials offering novel therapies
- comprehensive bone marrow/stem cell transplantation services
- support services
- access to complementary therapies through the Leonard P. Zakim Center for Integrated Therapies and Healthy Living
- follow-up care, including collaboration with your local (referring) physician
Precision Cancer Medicine
Clinicians at Dana-Farber Brigham Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn more about precision cancer medicine.
